Filing metadata

Accession number
0001628280-21-020527
Form type
Form 4
Filer
Aurinia Pharmaceuticals Inc.
CIK
CIK 1600620
Filed
Oct 26, 2021
Reporting period
Oct 25, 2021
Description
Insider transaction

Explore SEC Filings Hub